James D. McFadyen

Group Leader
Baker Heart and Diabetes Insitute
Melbourne, Victoria, Australia

Presentation(s):

• OC 17.4 - Engineering hyperechogenic colloids with thrombus-targeting capabilities from platelet membranes

  Sunday, June 23, 2024
  10:15 – 10:30 ICT

• PB0236 - Evaluation of real-world peri-operative outcomes in patients with haemophilia A (HA) with or without inhibitors on emicizumab prophylaxis in Australia

  Sunday, June 23, 2024
  13:45 – 14:45 ICT

• PB0565 - Phenotypic characterisation of congenital fibrinogen disorders in Australia

  Monday, June 24, 2024
  13:45 – 14:45 ICT

• OC 54.2 - Visceral Adipose Tissue is associated with an increased risk of venous thromboembolism independent of body mass index

  Tuesday, June 25, 2024
  09:45 – 10:00 ICT

• PB1179 - Differential effects of physiological agonists on the proteome of platelet-derived extracellular vesicles

  Tuesday, June 25, 2024
  13:45 – 14:45 ICT